Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Bispecifics: From Discovery to First in Human Masterclass – Registration Now Live
SMi are proud to announce that registration is now live for the upcoming masterclass entitled: Bispecifics: From discovery to first in human, taking place on the 7th December 2015 in London, UK. - August 16, 2015 - SAE Media Group
KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development
KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC
ABR Launches Bovine Polyomavirus Testing Service
ABR (now a VMRD division) announced today the availability of a new testing service that can detect the presence of bovine polyomavirus (BPyV) in animal origin products, master virus seeds, and other sample types. This infectivity assay, without using non-infectivity assays such as PCR, has the... - August 12, 2015 - VMRD, Inc.
Gensco Labs Announces LiDORx® Copay Program Mobile Platform for Pain Management
Text “LIDO to 37500” on your mobile device to receive the benefits of the Program Gensco Laboratories™ (www.genscolabs.com), A Specialty Pharmaceutical Company, announces a new mobile platform that uses innovative smart phone technology to provide copay assistance and facilitate... - August 11, 2015 - Gensco Labs
The Real Story About Rare and Ultra-Rare Disease from the Ultra Rare Diseases, Disorder & Disabilities Foundation
SMi Group reports (2015.08.07 – London, UK): The Ultra Rare Diseases, Disorder & Disabilities Foundation will attend the 4th annual Orphan Drugs and Rare Diseases Conference, to present “The real story about rare and ultra-rare disease.” - August 11, 2015 - SAE Media Group
ADC Contract Manufacturing Market: Opportunities Ahead
Antibody Drug Conjugates (ADCs) are a new class of therapeutic drugs consisting of a cytotoxic drug linked to a monoclonal antibody. These novel conjugates are believed to be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. - August 10, 2015 - Roots Analysis
Pinnacle 21 CEO Max Kanevsky Named to PharmaVOICE 100
Pinnacle 21 announced today that its president & CEO, Max Kanevsky, has been named to the prestigious PharmaVOICE 100 list of the most innovative and influential people in the life-sciences industry. - August 07, 2015 - Pinnacle 21
MHRA to Demonstrate How to Meet the Needs of the EU GDP at Cold Chain Distribution 2015
SMi Group reports: SMi Group are delighted to announce that the MHRA will be presenting at the 10th annual Cold Chain Distribution 2015 in London - August 07, 2015 - SAE Media Group
Leaders in the Biosimilar Sector - Sandoz, Oncobiologics, Merck, Samsung Bioepis - Will Meet at Biosimilars & Biobetters USA 2015
SMi Group reports: Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November. - August 07, 2015 - SAE Media Group
Global Home Infusion Therapy Devices Market: High Prevalence of Chronic Diseases to Lead Market to Register 9% CAGR by 2020
This report provides in-depth analysis and estimation of the home infusion therapy devices market for the period 2014–2020, considering 2014 as the base year for the calculation. - August 06, 2015 - Persistence Market Research
Ryan’s Quest Clinical Trial Grant for Steroid Alternative
The Ryan’s Quest Foundation, a non-profit organization specific to Duchenne muscular dystrophy, announced today the award of their most recent contribution toward the fight to end Duchenne muscular dystrophy. The Foundation has awarded ReveraGen BioPharma $50,000 towards a clinical trial for... - August 04, 2015 - Ryan's Quest
Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech
Israel Patent Office allows patent for treatment of hormone deficiencies and obesity in humans and pets. - August 01, 2015 - Braasch Biotech LLC
New Product Launched to Safeguard Patients from Counterfeit Medical Implants and Improved Recall Accuracy
New technology tracks medical implants; guards against counterfeits and offers ability to match recalls with patients. Matrix Medical announces the comprehensive TRACTUS solution to fill a much needed industry need. Product is fully in adherence to the GUDID and UDI requirements laid out by FDA. - July 29, 2015 - Matrix Medical Tracking Systems
The MCS Group, Inc. Opens New Office in Boston
The MCS Group, Inc., a national provider of outsourcing solutions, announced today that they have opened a new regional office in Boston, MA. This office will offer the full suite of MCS’s services, including but not limited to record retrieval, deposition, e-discovery, facilities management and back office solutions to help clients increase productivity while reducing operational costs. - July 27, 2015 - The MCS Group, Inc.
AutoGenomics to Introduce INFINITI® SMART – Sample-to-Result NextGen Automation Platform – at AACC 2015
AutoGenomics, Inc., a leader in providing automated molecular testing solutions to clinical laboratories, announced today that it will showcase its “Sample-to-Result” NextGen automation platform – INFINITI® SMART – at the American Association for Clinical Chemistry... - July 24, 2015 - AutoGenomics Inc.
HAEi Global Access Program for RUCONEST® Now Live
Unique patient organization-driven program is enabling people with Hereditary Angioedema (HAE) who cannot access effective treatments to receive medication for the first time - July 23, 2015 - Clinigen Group
Birth Defects Allegedly Linked to Zofran, Zofran Lawsuit Help Center Reviewing Potential Cases
A growing number of birth defects ranging from heart defects and clubfoot to cleft lip and palate have allegedly been linked to Zofran use during pregnancy in recent studies. - July 22, 2015 - Zofran Lawsuit Help Center
WiCON and PharmaGuys Launch Pharma China Training Institute
Pharma China Training Institute (PCTI, www.pharmachinatraining.com) was created by WiCON International Group LLC, the publisher of Pharma China, and PharmaGuys to meet the growing needs of healthcare/pharma MNCs in China for internationally-advanced professional training, coaching and other service solutions. - July 21, 2015 - WiCON International Group LLC
US Pharmaceutical Corporation Utilizes Probiotic Ferment Skin Care Technology to Drastically Improve Skin Peel Applications
US Pharmaceutical Corporation, one of the leading probiotic research and commercialization companies in the world, introduces a new collection of probiotic ferment-based micro skin peel products. The probiotic ferment technology is applied in a 24 hour micro peel regimen, which archives similar results to common peel systems, but without the side effects of redness/irritation and flaking of the skin. - July 20, 2015 - US Pharmaceutical Corporation
Metrics Contract Services Expands Staff with New Senior Formulation Scientist
Michael R. Mascarenas provides clients with quality formulation and process development of early-phase oral dosage forms. - July 15, 2015 - Metrics, Inc.
Anti-Counterfeit Pharmaceutical and Cosmetics Packaging Market is Expected to Reach $80.2 Billion, Globally, by 2020 - Allied Market Research
Counterfeiting of pharmaceutical and cosmetic products have emerged as a serious concern for the original product manufacturers. - July 10, 2015 - Allied Market Research
TPG Partners with Jakarta Against Drug Counterfeiting
The Peterson Group, a non-profit organization campaigning against illegal production, manufacture, distribution, importation and exportation of counterfeit drugs across the globe has been taking step by step realization of its goals and aspirations by partnering with one of the world’s most... - July 08, 2015 - The Peterson Group
Pharmaceutical Anti-Counterfeiting Technologies Market
The problem of counterfeit products has been a common challenge to all the industries across the globe. Counterfeit drugs create substantial public health hazards and cause crucial safety concerns. This field has attracted several companies which have developed many technologies with an aim to prevent counterfeiting in the pharma industry. - July 06, 2015 - Roots Analysis
Spaulding Clinical Research, LLC Expands Clinical Pharmacology Capabilities
CRO Completes 65-Bed Expansion to Increase Capacity to 200-Beds - July 05, 2015 - Spaulding Clinical Research, LLC
John T. Spitznagel Has Been Recognized by America’s Registry of Outstanding Professionals
Honored member, John T. Spitznagel of Glen Burnie, Maryland is a lifetime member of America’s Registry of Outstanding Professionals. He has now been included in the America’s Honor Roll for his accomplishments in the field of Healthcare Sales and Marketing. - July 03, 2015 - America's Registry of Outstanding Professionals
Global Osteoporosis Drugs Market Worth US$14.8 Billion by 2022, by Persistence Market Research
This report provides in-depth analysis and estimation of the osteoporosis drugs market for 2015– 2022, considering 2014 as the base year for calculation. Moreover, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report. - July 01, 2015 - Persistence Market Research
Prefilled Syringes Market, 2015-2025
Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern devices have become preferred devices for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. - June 29, 2015 - Roots Analysis
Antibody Drug Conjugates: Contract Manufacturing Market to Evolve Rapidly, Predicts Roots Analysis
Roots Analysis has announced addition of the “Antibody Drug Conjugates: Contract Manufacturing Market 2014-2024” report to their offering. The report provides an extensive study of the contract manufacturing opportunity for this emerging class of therapeutics. It identifies various CMOs... - June 28, 2015 - Roots Analysis
Elder Pharma Begins Exports of Superbrand Shelcal to More Than 25 Countries, Targets Rs 100 Crore from Global Sales
International rights of Shelcal still with Elder after selling off brand in Domestic markets to Torrent group last year; Elder’s wholly owned UK Subsidiary to spearhead European expansion plans. - June 27, 2015 - Elder Pharmaceuticals Ltd
Sanguine Corp. Inc. (OTCPK: SGUI) Announces Name Change to New Alliance BioSciences
Reflecting Their Broader Scope of Research and Development, Sanguine Corp. Inc. Obtains Shareholder Approval to Change Name to New Alliance BioSciences. - June 24, 2015 - Sanguine/New Alliance BioSciences
Global Diagnostic Imaging Devices Market to Expand Moderately at 5.2% CAGR from 2014 to 2020 - by MRRSE
According to this report, the increasing geriatric population base around the world coupled with the rising incidence of chronic diseases and injuries is the main factor behind the development of the global diagnostic imaging devices market. - June 21, 2015 - MRRSE
Liver Cancer Market Witnessing Innovative Therapies Focused on Re-Alignment of First-in-Class Molecular Targets with the Disease’s Causes - by MRRSE
It also pinpoints areas where maximum innovation is concentrated and offers insight into first-in-class therapies on the anvil (based on their development stage). Since patent and licensing trends are an inextricable aspect of the liver cancer market, these are discussed in detail as well. - June 21, 2015 - MRRSE
Pain Therapies Market Players Exhibit Keen Interest in Chronic Neuropathic Pain Treatment, Heralding New Deal Landscape - By MRRSE
The deal and co-development landscape of the pain therapies market has been meticulously assessed; critical changes in the licensing environment are also reviewed. - June 20, 2015 - MRRSE
Spaulding Clinical Research Adopts the Revolutionary ClinSpark™ eSource System
Spaulding Clinical Research, LLC, a full-service CRO headquartered in Southeastern Wisconsin announced today that they have completed the upgrade of their eSource platform and future capabilities to use Foundry Health, LLC’s ClinSpark™ system, the world’s only CDISC ODM certified... - June 19, 2015 - Spaulding Clinical Research, LLC
Diabetic Nephropathy Market to Hit US$ 3,145.9 Million by 2020, Lucrative Opportunities Exist for Combination Therapies - by MRRSE
The latest market research report added to the repository of Market Research Reports Search Engine (MRRSE) states that the diabetic nephropathy market will report a moderate CAGR at 5.6% from 2014 through 2020. The report, published by MRRSE, is titled ‘Global Market Study on Diabetic... - June 10, 2015 - MRRSE
Pyramid Healthcare Solutions to Exhibit at the Healthcare Financial Management Association - National Institute’s (ANI) 2015 Annual Conference
Pyramid Healthcare Solutions will exhibit at the Healthcare Financial Managements Association - National Institute’s 2015 Annual Conference on June 22-25 at the Orange County Convention Center in Orlando, FL. Critical topics including business intelligence, data analytics, payment trends... - June 08, 2015 - Pyramid Healthcare Solutions
Tabula Rasa HealthCare Receives Top Innovator Company Award
Tabula Rasa HealthCare is recognized for its "innovative solutions that are making an impact on cost, quality, and access in health care." TRHC develops offerings for the ever-growing segment of the healthcare system that is "at risk," providing tools and services to better manage risk. - June 05, 2015 - Tabula Rasa HealthCare
Human Insulin Market to Develop at a CAGR of 12.4% from 2014 to 2020 Owing to Expanding Predominance of Diabetes and Spiraling Number of Lifestyle Disorders - By MRRSE
As per this report, the global human insulin market had a total value of US$24,332.6 million in 2014 and is predicted to develop at a CAGR of 12.4% between 2014 and 2020, reaching US$49,197.3 million by 2020. - June 05, 2015 - MRRSE
Linking API Producers to API Customers - Connectivity Matters
The API Sourcing Database is a new Database to find producers of Active Pharmaceutical Ingredients including up to date quality information about the API. - June 02, 2015 - API Sourcing
Colorectal Cancer Therapeutics Market in Eight Developed Nations to See Japan Take a Lead in Growth Pace Through 2020 by MRRSE
Market Research Reports Search Engine (MRRSE), a leading portal offering business intelligence reports, has announced the addition of latest research titled "Colorectal Cancer (CRC) Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of... - May 31, 2015 - MRRSE
Global Biopharmaceuticals Market Will Grow US$ 2,78,232.9 Mn by 2020, by Persistence Market Research
This report provides in-depth analysis and estimation of the biopharmaceuticals market for the period 2014–2020, considering 2013 as the base year for the calculation. - May 28, 2015 - Persistence Market Research
H. Perry Fell, Experienced BioTech Executive, Joins Board of Recursion Pharmaceuticals
H. Perry Fell, past CEO of Seattle Genetics and NanoString, joins the Board of Recursion Pharmaceuticals. Recursion is an emerging biotech company seeking to combine the best elements of computation and functional genetics to rapidly identify novel therapeutic opportunities for genetic diseases. - May 27, 2015 - Recursion Pharmaceuticals
Patients Embrace gammaCore - the New Non Pharmacologic Treatment for Migraines
A poster at the International Headache Congress(1), in Valencia, reports on a study which examined patients’ attitude to electroCore’s non-invasive vagus nerve stimulation (nVNS) treatment for migraines. The research by the Headache Centre in Rome(2) asked 60 patients why they started... - May 23, 2015 - electroCore
Clinigen Group and Pharming Initiate “HAEi GAP” Global Access Program for RUCONEST®
Unique patient organization-driven program will enable patients with hereditary angeoedema (HAE) who cannot access effective treatments to receive medication for the first time. - May 21, 2015 - Clinigen Group
Spaulding Clinical Research, LLC Wins CRO Leadership Award
Spaulding Clinical Research, LLC (SCR) announced it has been recognized for excellence in clinical research by biopharmaceutical executives surveyed for the Life Science Leader magazine’s 2015 CRO Leadership Awards. - May 20, 2015 - Spaulding Clinical Research, LLC
Interactive Networking Opportunities on Agenda at Pharmaceutical Procurement and Strategic Sourcing Conference
Risk-Sharing Partnerships, Global Procurement Strategy Among Discussion Topics - May 16, 2015 - Q1 Productions
Medical Science Liaison Society Establishes Global Advisory Committee
Team Boasts Breadth, Depth with 17 Members from Around the World - May 16, 2015 - Thought Leader Select
ValueCentricIQ Unveils Innovative Mobile App
The app delivers comprehensive insights, industry trends, and benchmarking tools to the Pharmaceutical IndustryVCIQ Industry Benchmark app is now available on iOS, Android, and Desktop devices - May 13, 2015 - ValueCentric
Parenteral Drug India Ltd. (PDPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Market Reports on India presents the report on "Parenteral Drug India Ltd. (PDPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile." This is a report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. - May 13, 2015 - Market Reports on India
Save Time Job Posting - Use Job Scraping
Job scraping tool can save pharma recruiters and employers huge amounts of time. - May 07, 2015 - PharmiWeb.com